Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (641-650 of 662) with videos related to

Pageof 67
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|July 1, 2022
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and BeyondSusan V Jennings, Celeste C Finnerty, Jessica S Hobart, et al.
Blood|May 1, 2020
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease driversAlexandre Fagnan, Frederik Otzen Bagger, Maria-Riera Piqué-Borràs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosisCelalettin Ustun, Andreas Reiter, Bart L Scott, et al.
The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
International Journal of Laboratory Hematology|September 14, 2020
Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failureCelalettin Ustun, Elizabeth A Morgan, Ethan M Ritz, et al.
Theranostics|January 4, 2021
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosisHanneke C Kluin-Nelemans, Mohamad Jawhar, Andreas Reiter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2018
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and PerspectivesPeter Valent, Joanna N G Oude Elberink, Aleksandra Gorska, et al.
Leukemia|September 21, 2021
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, et al.
Cancer Medicine|August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood Advances|April 9, 2024
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREMJohannes Lübke, Alicia Schmid, Deborah Christen, et al.
Pageof 67

Showing results (641-650 of 662) with videos related to

Sort By:
Pageof 67
The Journal of Allergy and Clinical Immunology. in Practice|July 1, 2022
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and BeyondSusan V Jennings, Celeste C Finnerty, Jessica S Hobart, et al.
Blood|May 1, 2020
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease driversAlexandre Fagnan, Frederik Otzen Bagger, Maria-Riera Piqué-Borràs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosisCelalettin Ustun, Andreas Reiter, Bart L Scott, et al.
The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
International Journal of Laboratory Hematology|September 14, 2020
Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failureCelalettin Ustun, Elizabeth A Morgan, Ethan M Ritz, et al.
Theranostics|January 4, 2021
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosisHanneke C Kluin-Nelemans, Mohamad Jawhar, Andreas Reiter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2018
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and PerspectivesPeter Valent, Joanna N G Oude Elberink, Aleksandra Gorska, et al.
Leukemia|September 21, 2021
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, et al.
Cancer Medicine|August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood Advances|April 9, 2024
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREMJohannes Lübke, Alicia Schmid, Deborah Christen, et al.
Pageof 67